The Expression of Decoy Receptor 3 in Peripheral Blood Monocytes of Rheumatoid Arthritis Patient

Article Preview

Abstract:

To investigate DcR3 mRNA levels of peripheral blood monocytes in rheumatoid arthritis(RA),and analyzes the correlation between the DcR3 Levels of Peripheral Blood and the Disease Activity in Rheumatoid Arthritis Patient. The expression levels of DcR3 mRNA in peripheral Blood monocytes of 82 RA patients and 53 healthy controls were detected by real-time polymerase chain reaction. The expression levels of DcR3 mRNA of active stage in RA patients were higher than that of remission stage in RA patients and healthy controls(P<0.05); The correlationships between DcR3 mRNA levels and active renal score (DAS28)show positive correlation. The expression levels of peripheral blood DcR3 does significant increase in RA active patients and it is closely related with the activity of the disease which suggesting that DcR3 migh involved in the pathological process.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

848-851

Citation:

Online since:

June 2013

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2013 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] Fournier, C., Where do T cells stand in rheumatoid arthritis? Joint Bone Spine, 2005. 72(6): pp.527-32.

DOI: 10.1016/j.jbspin.2004.12.012

Google Scholar

[2] Lee, C.S., C.Y. Hu, H.F. Tsai, et al., Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematosus. Clin Exp Immunol, 2008. 151(3): pp.383-90.

DOI: 10.1111/j.1365-2249.2007.03579.x

Google Scholar

[3] Otsuki, T., A. Tomokuni, H. Sakaguchi, et al., Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients. Clin Exp Immunol, 2000. 119(2): pp.323-7.

DOI: 10.1046/j.1365-2249.2000.01132.x

Google Scholar

[4] Arnett, F.C., S.M. Edworthy, D.A. Bloch, et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum, 1988. 31(3): pp.315-24.

DOI: 10.1002/art.1780310302

Google Scholar

[5] Saraux, A., L. Gossec, P. Goupille, et al., Cost-effectiveness modelling of biological treatment sequences in moderate to severe rheumatoid arthritis in France. Rheumatology (Oxford), 2010. 49(4): pp.733-40

DOI: 10.1093/rheumatology/kep434

Google Scholar

[6] Canete, J.D., S.E. Martinez, J. Farres, et al., Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann Rheum Dis, 2000. 59(4): pp.263-8.

DOI: 10.1136/ard.59.4.263

Google Scholar

[7] Bamias, G., S.I. Siakavellas, K.S. Stamatelopoulos, et al., Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis. Clin Immunol, 2008. 129(2): pp.249-55.

DOI: 10.1016/j.clim.2008.07.014

Google Scholar

[8] Hayashi, S., Y. Miura, K. Tateishi, et al., Decoy receptor 3 is highly expressed in patients with rheumatoid arthritis. Mod Rheumatol, 2010. 20(1): pp.63-8.

DOI: 10.1007/s10165-009-0240-7

Google Scholar